NET PROFIT (x1000 SEK)
EMPLOYEES
Biocreative AB
Closing information (x1000 SEK)
| Closing information | 2025/08 | 2024/08 | 2023/08 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
2
|
2
|
62 |
| Earnings before taxes |
22
|
-22
|
7 |
| EBITDA |
-66
|
-72
|
-47 |
| Total assets |
1,546
|
1,519
|
1,555 |
| Current assets |
407
|
144
|
183 |
| Current liabilities |
1,277
|
1,264
|
1,276 |
| Equity capital |
260
|
242
|
260 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/08 | 2024/08 | 2023/08 |
| Solvency |
16.8%
|
15.9%
|
16.7% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
1.6%
|
-1.3%
|
4.4% |
| Current ratio |
31.9%
|
11.4%
|
14.3% |
| Return on equity (ROE) |
8.5%
|
-9.1%
|
2.7% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/08 | 2024/08 | 2023/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.